chrX-149933793-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001013845.2(EOLA2):c.82C>T(p.Arg28Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,199,417 control chromosomes in the GnomAD database, including 3 homozygotes. There are 84 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001013845.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EOLA2 | NM_001013845.2 | c.82C>T | p.Arg28Cys | missense_variant | 4/5 | ENST00000370406.8 | NP_001013867.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EOLA2 | ENST00000370406.8 | c.82C>T | p.Arg28Cys | missense_variant | 4/5 | 1 | NM_001013845.2 | ENSP00000359434 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 26AN: 109794Hom.: 0 Cov.: 21 AF XY: 0.000183 AC XY: 6AN XY: 32812
GnomAD3 exomes AF: 0.000281 AC: 51AN: 181534Hom.: 0 AF XY: 0.000287 AC XY: 19AN XY: 66288
GnomAD4 exome AF: 0.000184 AC: 201AN: 1089576Hom.: 3 Cov.: 31 AF XY: 0.000219 AC XY: 78AN XY: 355742
GnomAD4 genome AF: 0.000237 AC: 26AN: 109841Hom.: 0 Cov.: 21 AF XY: 0.000183 AC XY: 6AN XY: 32871
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.82C>T (p.R28C) alteration is located in exon 4 (coding exon 1) of the CXorf40B gene. This alteration results from a C to T substitution at nucleotide position 82, causing the arginine (R) at amino acid position 28 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | EOLA2: PP3, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at